Literature DB >> 12466710

Cardiac magnetic resonance imaging: a "one-stop-shop" evaluation of myocardial dysfunction.

Michael Poon1, Valentin Fuster, Zahi Fayad.   

Abstract

A faster and more precise method for determining hibernating myocardium remains the holy grail of noninvasive cardiac imaging. Nuclear or echocardiogram-based imaging techniques have been the key modalities for evaluating important markers of cardiac viability. Advances in hardware and software for cardiac magnetic resonance imaging (CMRI) have transformed this valuable research tool into an important part of current noninvasive cardiac imaging. Due to its high spatial resolution and large field of view, CMRI offers unsurpassed images of the heart and its function. A combination of dobutamine stress function, vasodilator-induced stress perfusion, and delayed hyperenhancement of contrast within the injured myocardium has become a one-stop shop in the routine assessment of cardiac viability following transient ischemic insult or myocardial infarction.

Entities:  

Mesh:

Year:  2002        PMID: 12466710     DOI: 10.1097/00001573-200211000-00013

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  15 in total

1.  Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure?

Authors:  Brian J Schietinger; Szilard Voros; David C Isbell; Craig H Meyer; John M Christopher; Christopher M Kramer
Journal:  Int J Cardiovasc Imaging       Date:  2007-01-10       Impact factor: 2.357

2.  Single Tc99m Sestamibi injection, double acquisition gated SPECT after stress and during low-dose dobutamine infusion: a new suggested protocol for evaluation of myocardial perfusion.

Authors:  Babak Fallahi; Davood Beiki; Ali Gholamrezanezhad; Babak Mahmoudian; Kianoush Ansari Gilani; Mohammad Eftekhari; Armaghan Fard-Esfahani; Zhila Mohseni; Mohsen Saghari
Journal:  Int J Cardiovasc Imaging       Date:  2008-06-18       Impact factor: 2.357

Review 3.  Assessment of myocardial ischemia and viability using cardiac magnetic resonance.

Authors:  Javier Sanz; Teresa Rius; Paola Kuschnir; Rafael Salguero Bodes; Michael Poon
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

4.  Functional cardiac magnetic resonance imaging (MRI) in the assessment of myocardial viability and perfusion: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2003-11-01

5.  Prognostic value of T1-mapping in TAVR patients: extra-cellular volume as a possible predictor for peri- and post-TAVR adverse events.

Authors:  Jonathan Nadjiri; Hanna Nieberler; Eva Hendrich; Albrecht Will; Costanza Pellegrini; Oliver Husser; Christian Hengstenberg; Andreas Greiser; Stefan Martinoff; Martin Hadamitzky
Journal:  Int J Cardiovasc Imaging       Date:  2016-07-26       Impact factor: 2.357

6.  Initial results of cardiac imaging at 7 Tesla.

Authors:  C J Snyder; L DelaBarre; G J Metzger; P-F van de Moortele; C Akgun; K Ugurbil; J T Vaughan
Journal:  Magn Reson Med       Date:  2009-03       Impact factor: 4.668

Review 7.  Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease.

Authors:  Paul Cremer; Rory Hachamovitch; Balaji Tamarappoo
Journal:  Semin Nucl Med       Date:  2014-07       Impact factor: 4.446

8.  Relation between wall thickening on gated perfusion SPECT and functional recovery after coronary revascularization in patients with previous myocardial infarction.

Authors:  Mario Petretta; Giovanni Storto; Wanda Acampa; Valeria Sansone; Laura Evangelista; Letizia Spinelli; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-07-31       Impact factor: 9.236

9.  Cardiovascular magnetic resonance imaging in experimental models.

Authors:  Anthony N Price; King K Cheung; Jon O Cleary; Adrienne E Campbell; Johannes Riegler; Mark F Lythgoe
Journal:  Open Cardiovasc Med J       Date:  2010-11-26

10.  Myocardial viability: what we knew and what is new.

Authors:  Adel Shabana; Ayman El-Menyar
Journal:  Cardiol Res Pract       Date:  2012-09-05       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.